Report overview
This report contains market size and forecasts of Cytomegalovirus Therapeutics in Global, including the following market information:
Global Cytomegalovirus Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cytomegalovirus Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ganciclovir/Valganciclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cytomegalovirus Therapeutics include AbbVie, Actavis, Clinigen Group, Merck, Perrigo Company, Roche and Bausch Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cytomegalovirus Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cytomegalovirus Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cytomegalovirus Therapeutics Market Segment Percentages, by Type, 2021 (%)
Ganciclovir/Valganciclovir
Foscarnet
Cidofovir
Global Cytomegalovirus Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cytomegalovirus Therapeutics Market Segment Percentages, by Application, 2021 (%)
CMV Retinitis
Pneumonia
Gastrointestinal Ulcers
Encephalitis
Mouth Ulcers
Pharyngitis
Global Cytomegalovirus Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cytomegalovirus Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cytomegalovirus Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cytomegalovirus Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Actavis
Clinigen Group
Merck
Perrigo Company
Roche
Bausch Health
